Viewing StudyNCT00506779



Ignite Creation Date: 2024-05-05 @ 6:34 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00506779
Status: TERMINATED
Last Update Posted: 2020-11-18
First Post: 2007-07-23

Brief Title: GleevecTaxol for Patients With Uterine Papillary Serous Carcinoma
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-12-29
Start Date Type: ACTUAL
Primary Completion Date: 2015-04
Primary Completion Date Type: ACTUAL
Completion Date: 2015-04
Completion Date Type: ACTUAL
First Submit Date: 2007-07-23
First Submit QC Date: July 23 2007
Study First Post Date: 2007-07-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-11-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-10-26
Last Update Post Date: 2020-11-18
Last Update Post Date Type: ACTUAL